Morphinome - A meta-analysis applied to proteomics studies in morphine dependence

Proteomics

Volumn 11, Issue 1, 2011, Pages 5-21

  Bodzon Kułakowska, Anna ^a   Kułakowski, Konrad ^a   Drabik, Anna ^a   Moszczynski, Adam ^a   Silberring, Jerzy ^a   Suder, Piotr ^a  

^a AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Addiction; Bioinformatics; Meta analysis; Morphine; Morphinome

Indexed keywords

PROTEOME;

AMINO ACID SEQUENCE; BIOINFORMATICS; DATA BASE; HUMAN; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; STANDARDIZATION;

ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HUMANS; MORPHINE DEPENDENCE; PROTEOMICS;

ANIMALIA;

EID: 78650333811     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900848     Document Type: Review

References (54)

1. Goldstein, A., Lowney, L. I., Pal, B. K., Stereospecific and nonspecific interaction of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. USA 1971, 68, 1742-1747.
2. Preston, K. L., Drug abstinence effects: opioids. Br. J. Addict. 1991, 86, 1641-1646.
3. Bhargava, H. N., Drugs that modify opioid tolerance, physical dependence and abstinence symptoms: preclinical and clinical studies. NIDA Res. Monogr. 1995, 147, 53-83.
4. Koob, G. F., Le Moal, M., Neurobiology of Addiction, Elsevier Inc., UK, 2006.
5. Vetulani, J., Drug addiction. part I. psychoactive substances in the past and presence. Pol. J. Pharmacol. 2001, 53, 201-214.
6. Clark, P. A., Sillup, G. P., Capo, J. A., Afghanistan, poppies, and the global pain crisis. Med. Sci. Monit. 2010, 16, 49-57.
7. Clatts, M. C., Giang, Ie. M., Goldsamt, L. A., Yi, H., Novel heroin injection practices: implications for transmission of HIV and other bloodborne pathogens. Am. J. Prev. Med. 2007, 32, 226-233.
8. Oviedo-Jokes, E., Brissette, S., Marsch, D. C., Lauzon, P. et al., Diacetylmorphine versus methadone for the treatment of opioid addiction. N. Engl. J. Med. 2009, 361, 777-786.
9. Thiede, H., Hagan, H., Campbell, J. V., Strathdee, S. A. et al., Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007, 91, 39-47.
10. Nestler, E. J., Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 2004, 25, 210-218.
11. Bodzon-Kulakowska, A., Bierczynska-Krzysik, A., Drabik, A., Noga, M. et al., Morphinome-proteome of the nervous system after morphine treatment. Amino Acids 2005, 28, 13-19.
12. Wilson, D.B., Lipsey, M., Practical Meta-analysis, Applied Social Research Methods, 2000, 49, ISBN 0-7619-2167-2, London, UK.
13. Van Hoof, D., Heck, A. J. R., Krijgsveld, J., Mummery, C. L., Proteomics and human embryonic stem cells. Stem Cell Res. 2008, 1, 169-182.
14. Piersma, S. R., Broxterman, H. J., Kapci, M., de Haas, R. R. et al., Proteomics of the trap-induced platelet releasate. J. Proteomics 2009, 72, 91-109.
15. Prokesch, A., Hackl, H., Hakim-Weber, R., Bornstein, S. R. et al., Novel insights into adipogenesis from omics data. Curr. Med. Chem. 2009, 16, 2952-2964.
16. Li, C., Mao, X., Wei, L., Genes and (common) pathways underlying drug addiction. PLoS Comput. Biol. 2008, 4, e2.
17. Bierczynska-Krzysik, A., Bonar, E., Drabik, A., Noga, M. et al., Rat brain proteome in morphine dependence. Neurochem. Int. 2006, 49, 401-406.
18. Yang, L., Sun, Z. S., Zhu, Y., Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J. Proteome Res. 2007, 6, 2239-2247.
19. Bierczynska-Krzysik, A., Pradeep John, J. P., Silberring, J., Kotlinska, J. et al., Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int. J. Mol. Med. 2006, 18, 775-784.
20. Li, K. W., Jimenez, C. R., van der Schors, R. C., Hornshaw, M. P. et al., Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6, 2003-2008.
21. Chen, X. L., Lu, G., Gong, Y. X., Zhao, L. C. et al., Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment. Cell Res. 2007, 8, 689-700.
22. Shui, H., Ho, S., Wang, J., Wu, C. et al., Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection. Proteomics 2007, 7, 796-803.
23. Li, Q., Zhao, X., Zhong, L., Yang, H. et al., Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. Eur. J. Pharmacol. 2009, 612, 21-28.
24. Moulédous, L., Neasta, J., Uttenweiler-Joseph, S., Stella, A. et al., Long-term morphine treatment enhances proteasome-dependent degradation of g beta in human neuroblastoma sh-sy5y cells: correlation with onset of adenylate cyclase sensitization. Mol. Pharmacol. 2005, 68, 467-476.
25. Neasta, J., Uttenweiler-Joseph, S., Chaoui, K., Monsarrat, B. et al., Effect of long-term exposure of sh-sy5y cells to morphine: a whole cell proteomic analysis. Proteome Sci. 2006, 4, 23.
26. Xu, H., Wang, X., Zimmerman, D., Boja, E. S. et al., Chronic morphine up-regulates g alpha12 and cytoskeletal proteins in chinese hamster ovary cells expressing the cloned mu opioid receptor. J. Pharmacol. Exp. Ther. 2005, 315, 248-255.
27. Bodzon-Kulakowska, A., Suder, P., Mak, P., Bierczynska-Krzysik, A. et al., Proteomic analysis of striatal neuronal cell cultures after morphine administration. J. Sep. Sci. 2009, 32, 1200-1210.
28. Suder, P. K., Bodzon-Kulakowska, A., Mak, P., Bierczynska-Krzysik, A. et al., The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. J. Proteome Res. 2009, 8, 4633-4640.
29. Prokai, L., Zharikova, A. D., Stevens, S. M. J., Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass sp6ectrometry. J. Mass Spectrom. 2005, 40, 169-175.
30. Moron, J. A., Abul-Husn, N. S., Rozenfeld, R., Dolios, G. et al., Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol. Cell. Proteomics 2007, 6, 29-42.
31. Kim, S., Chudapongse, N., Lee, S., Levin, M. C. et al., Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res. Mol. Brain Res. 2005, 133, 58-70.
32. Hyman, S. E., Malenka, R. C., Nestler, E. J., Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 2006, 29, 565-598.
33. Banker, G., Goslin K., Culturing Nerve Cells, A Bradford Book The MIT Press, London, UK 1998.
34. Barker, J. L., Dufy, B., Harrison, N. L., Owen, D. G., MacDonald, J. F., Signal transduction mechanisms in cultured CNS neurons and clonal pituitary cells. Neuropharmacology 1987, 26, 941-955.
35. Raghavendra, V., Tanga, F. Y., DeLeo, J. A., Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 2004, 29, 327-334.
36. Narita, M., Miyatake, M., Narita, M., Shibasaki, M. et al., Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 2006, 31, 2476-2488.
37. Narita, M., Suzuki, M., Narita, M., Niikura, K. et al., Mu-opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: comparison between etorphine and morphine. Neuroscience 2006, 138, 609-619.
38. Chneiweiss, H., Glowinski, J., Premont, J., Mu and delta opiate receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primary cultures. J. Neurosci. 1988, 8, 3376-3382.
39. Stiene-Martin, A., Zhou, R., Hauser, K. F., Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Glia 1998, 22, 249-259.
40. Kennedy, C., Henderson, G., Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single sh-sy5y cells after chronic exposure to morphine in vitro. Mol. Pharmacol. 1991, 40, 1000-1005.
41. Karthik, P., Jayapal, K. F., Wlaschin, W.-S. Hu., Miranda, G. S., Yap, Recombinant protein therapeutics from cho cells - 20 years and counting. Chem. Eng. Progress, 2007, 103, 40-47.
42. Kennedy, M. J., Ehlers, M. D., Organelles and trafficking machinery for postsynaptic plasticity. Annu. Rev. Neurosci. 2006, 29, 325-362.
43. Sheng, M., Molecular organization of the postsynaptic specialization. Proc. Natl. Acad. Sci. USA 2001, 98, 7058-7061.
44. Hering, H., Lin, C., Sheng, M., Lipid rafts in the maintenance of synapses, dendritic spines, and surface ampa receptor stability. J. Neurosci. 2003, 23, 3262-3271.
45. Jacobs, E. H., Smit, A. B., de Vries, T. J., Schoffelmeer, A. N. M., Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol. Sci. 2003, 24, 566-573.
46. Kim, M. S., Cheong, Y. P., So, H. S., Lee, K. M. et al., Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of g protein and phosphatidylinositol 3-kinase (pi3 kinase). Biochem. Pharmacol. 2001, 61, 779-786.
47. Moulédous, L., Diaz, M. F., Gutstein, H. B., Modulation of extracellular signal-regulated kinase (erk) activity by acute and chronic opioid treatment in neuronal and glial cell lines. J. Neurochem. 2004, 90, 1371-1377.
48. Vlaskovska, M., Kasakov, L., Suder, P., Silberring, J. et al., Biotransformation of nociceptin/orphanin fq by enzyme activity from morphine-naive and morphine-treated cell cultures. Brain Res. 1999, 818, 212-220.
49. Schulteis, G., Heyser, C. J., Koob, G. F., Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. Psychopharmacology (Berl.) 1997, 129, 56-65.
50. Azorlosa, J. L., Stitzer, M. L., Greenwald, M. K., Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history. Psychopharmacology 1994, 114, 71-80.
51. Haghparast, A., Khani, A., Lashgari, R., Fallahian, S., Reducing the time and dose of morphine application used in marshall and grahame-smith method for induction of morphine tolerance and dependence in mice. Drug Alcohol Depend. 2008, 93, 185-189.
52. Bairoch, A., Apweiler R., Wu, C.H., Uniprot knowledgebase - user manual.
53. Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H. et al., Panther: a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13, 2129-2141.
54. Hamacher, M., Meyer, H. E., Hupo brain proteome project: aims and needs in proteomics. Exp. Rev. Proteomics 2005, 2, 1-3.